29 participants
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-22
- Start Date:
- 2015-01-30
- Completion:
- 2022-11-30
Conditions
- Cirrhosis
- Hepatitis B Infection
- Hepatitis C Infection
- Metastatic Malignant Solid Neoplasm
- Recurrent Hepatocellular Carcinoma
- Recurrent Malignant Solid Neoplasm
- Refractory Malignant Neoplasm
- Stage IV Hepatocellular Carcinoma AJCC v7
- Unresectable Solid Neoplasm
Interventions
- OTHER
- BIOLOGICAL
- DRUG
No Results Yet